"Braining" is a clinical method for physical exercise as adjunctive therapy in psychiatric care. The core components are personnel-led group training sessions and motivating contact with psychiatric staff, as well as measurement and evaluation before and after the training period of 12 weeks. Objective. This study aims to describe the clinical and demographic variables in the population of patients who participated in Braining 2017-2020, investigate the feasibility of Braining, and analyse perceived short-term effects and side effects of Braining regarding psychiatric and somatic symptoms. Method. The project is a retrospective, descriptive study. Patients at Psykiatri Sydväst (PSV, Psychiatric Clinic Psychiatry Southwest, Stockholm) who participated in Braining 2017-2020 during at least 3 training sessions, will be asked for inclusion. Medical and demographic data, as well as patient treatment evaluations, are already available in medical records. Additionally, an extended 2-year long-term follow-up will be carried out. This includes blood and hair sample, physical examination as well as qualitative interviews with a representative subgroup.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Descriptives of the population
Timeframe: 2017-2020
Feasibility - The population´s participation in Braining
Timeframe: 2017-2020
PHQ-9 (Patient Health Questionnaire - 9 items)
Timeframe: At the individual's start of participation in Braining (T0)
PHQ-9 (Patient Health Questionnaire - 9 items)
Timeframe: At inclusion (Ti)
GAD-7 (Generalised Anxiety Disorder Assessment - 7 items)
Timeframe: At the individual's start of participation in Braining (T0)
GAD-7 (Generalised Anxiety Disorder Assessment - 7 items)
Timeframe: At inclusion (Ti)
CGI-S (Clinical Global Impressions - Severity Scale)
Timeframe: At the individual's start of participation in Braining (T0)
CGI-S (Clinical Global Impressions - Severity Scale)
Timeframe: At inclusion (Ti)
Blood pressure
Timeframe: At the individual's start of participation in Braining (T0)
Blood pressure
Timeframe: At inclusion (Ti)
BMI (Body Mass Index)
Timeframe: At the individual's start of participation in Braining (T0)
BMI (Body Mass Index)
Timeframe: At inclusion (Ti)
FBS (Fasting Blood Sugar)
Timeframe: At the individual's start of participation in Braining (T0)
FBS (Fasting Blood Sugar)
Timeframe: At inclusion (Ti)
EQ-5D ( EQ-5D™ is a trade mark of the EuroQol Group)
Timeframe: At the individual's start of participation in Braining (T0)
EQ-5D ( EQ-5D™ is a trade mark of the EuroQol Group)
Timeframe: At inclusion (Ti)